NEPHROS INC — Director's Dealing 2025

Nov 13, 2025

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: NEPHROS INC (NEPH)
CIK: 0001196298
Period of Report: 2025-11-10

Reporting Person: Amron Arthur H (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2025-11-10	Common Stock	A	5391	—	Acquired	131272	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Option (Right to Buy)	$2.14	2034-05-14	Common Stock (7323)	7323	Direct
Stock Option (Right to Buy)	$1.47	2035-01-01	Common Stock (7050)	7050	Direct

Footnotes

F1: This option vests as to 2,441 shares on each of 5/14/24, 5/14/25 and 5/14/26.

F2: This option vests as to 2,350 shares on each of 1/1/25, 1/1/26 and 1/1/27.